spacer
home > pmps > summer 2002 > mes or mess? - the creation of management information and the effective use of production data in pharmaceutical manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES or Mess? - The Creation of Management Information and the Effective Use of Production Data in Pharmaceutical Manufacturing

As a participant in the IT industry and one that has implemented a wide variety of production information systems in several industries, I have seen all too many buzzwords come and go. The name of the game today is management execution systems (MES). According to the hype, MES delivers totally integrated information systems from the production line to the boardroom - a thrilling thought! This article will look at the different areas that are involved in MES and analyse the different data and information needs from the various participants in the production, delivery and decision processes.

Although Table 1 is not exhaustive - neither when it comes to describing the needs of each and every role, nor all the possible roles involved in the production process - it is sufficient for the purpose of analysing the various aspects of an MES system and the fundamental differences in information needs throughout the information chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Espen Gisvold, Managing Director of ESGH Espen Gisvold is the Managing Director of ESGH. He graduated from the University of Oslo, Norway in 1985 in Mathematics, Physics and Informatics and gained a Bachelor's degree in Informatics, which focused on numerical analysis.
Subsequently, Espen spent 10 years working with Saga Petroleum ASA, where he subsequently established and was responsible for the production information management system for the operations division. In 1996, Espen joined Inenco - a software house specialising in MES systems - as Product Quality Manager. In May 2000, he moved to Agilent Technologies as Test Lead Engineer.

spacer
Espen Gisvold
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

[Noáin, April 22, 2020] 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement